Skip to main content
A headshot of Eric B. Larson, MD, MPH, MACP

Eric B. Larson, MD, MPH, MACP


National Academy of Medicine member, Dr. Eric Larson has practiced medicine and instructed medical students for over four decades. The focus of his work has been on geriatrics and conditions such as dementia, Alzheimer’s disease, Parkinson’s disease, fall-related injuries, traumatic brain injuries, and sleep disturbance. Dr. Larson has written many book chapters as well as hundreds of publications. He serves on several editorial boards for medical journals.

Education and Training

  • BA, Stanford University
  • MD, Harvard Medical School
  • Internship, Beth Israel Hospital, Harvard Medical School
  • Assistant Residency, Beth Israel Hospital, Harvard Medical School
  • Senior Fellow, Robert Wood Johnson Clinical Scholar, Department of Medicine, University of Washington
  • MPH, University of Washington School of Public Health
  • Chief Resident, University Hospital Seattle


Selected Prior Positions

1989-2002 Associate Dean for Clinical Affairs
University of Washington School of Medicine
1989-2002 Medical Director
University of Washington Medical Center in Seattle
2002-2006 Director
Group Health Cooperative, Center for Health Studies
2002-2017 Senior Investigator and Executive Director
Group Health Research Institute
2004 Chair
Board of Regents, American College of Physicians
2004 Robert J. Glaser Award
Society of General Internal Medicine
2006 Master
American College of Physicians
2006 Laureate Award
Washington Chapter, American College of Physicians
2006-2017 Executive Director
Group Health Research Institute
2007 Elected Member
National Academy of Medicine (Formerly IOM) of the National Academies of Science
2011-2017 Vice President for Research
Group Health Cooperative
2017-present Senior Investigator and Executive Director
Kaiser Permanente Washington Health Research Institute
2017-present Vice President
Research and Health Care Innovation, Kaiser Foundation Health Plan of Washington

Selected Publications

Peer-reviewed research manuscripts

  • Harding B, Weiss N, Walker R, Larson E, Dublin S. Proton pump inhibitor use and risk of fractures among an older adult cohort. Pharmacoepidemiol Drug Saf 2018;27:586-603. [Epub ahead of print, Feb 28, 2018]
  • Fraade-Blanar L, Ebel B, Larson E, Sears J, Thompson H, Chan KC, Crane P. Cognitive decline and older driver crash risk. J Am Geriatr Soc 2018. [Epub ahead of print, April, 2018]
  • Hohman TJ, Dumitrescu L, Barnes L, Thambisetty M, Beecham G, Kunkle B, Gifford K, Bush WS, Chibnik L, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick S, Keene D, Montine TJ, Schellenberg G, Haines JL, Zetterberg H, Larson EB, Johnson S, Albert M, Bennett DA, Schneider JA, Jefferson A for the Alzheimer’s Disease Genetics Consortium. Sex-specific effects of apolipoprotein E on cerebrospinal fluid tau levels. JAMA Neurology 2018. doi:10.1001/jamaneurol.2018.0821 [Epub ahead of print, May 7, 2018]
  • Wei-Qi W, Li X, Feng Q, Kubo M, Kullo IJ, Peissig PL, Karlson EW, Jarvik GP, Lee MTM, Shang N, Larson EA, Edwards T, Shaffer C, Mosley JD, Maeda S, Horikoshi M, Ritchie M, Williams MS, Larson EB, Crosslin DR, Bland ST, Racheco JA, Rasmussen-Torvik L, Cronkite D, Hripcsak G, Cox NJ, Wilke RA, Stein CM, Rotter JI, Momozawa Y, Roden DM, Krauss RM, Denny JC. LPA variants are associated with residual cardiovascular risk in patients receiving statins. Circulation 2018; pii: CIRCULATIONAHA.117.031356. doi: 10.1161/CIRCULATIONAHA.117.031356. [Epub ahead of print, April 27, 2018]
  • Williams J, Chung W, Fedotov A, Kiryluk K, Weng C, Connolly J, Harr M, Hakonarson H, Leppig K, Larson E, Jarvik G, Veenstra D, Hoell C, Smith M, Hom I, Perterson J, Williams M. Harmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes to ClinGen Outcome/Intervention Pairs. Healthcare 6, 83; doi:10.3390/healthcare6030083.